# Trial: Glutotrack
## ID: NCT06864546

### Description
(Not provided in snippet, but inferred as T2D study)

### Inclusion Criteria
- Non-insulin treated T2D diagnosis (not treated at all or only with metformin);
- Physically inactive (less than 150 minutes/week of moderate physical activity);
- Age between 40 and 70;
- HbA1c below 8.5%.

### Exclusion Criteria
- Diabetes diagnosis less than 3 years before the study initiation;
- Pregnancy;
- Symptomatic heart disease, e.g. history of myocardial infarction, coronary bypass, stenting procedure, angina, or any ischemic cerebrovascular event;
- Use of a medication that significantly impacts glucose metabolism (oral steroids);
- Use of a medication that significantly lowers heart rate (beta blockers, reserpine, guanethidine, methyldopa, clonidine, cimetidine, digitalis, calcium channel blockers, amiodarone, antiarrhythmic drugs, or lithium);
- Atrial fibrillation;
- Use of an electronic pacemaker.
